166 related articles for article (PubMed ID: 12794535)
41. Acute myeloid leukemia presenting in a mother and daughter pair with the identical acquired karyotypic abnormality consisting of inversion 3q21q26 and monosomy 7: a review of possible mechanisms.
Lawrie A; Stevenson DA; Doig TN; Vickers MA; Culligan DJ
Cancer Genet; 2012 Nov; 205(11):599-602. PubMed ID: 23064135
[TBL] [Abstract][Full Text] [Related]
42. Monosomy 7 myelodysplasia in childhood. Two case reports.
Yeşilipek MA; Lüleci G; Velipaşaoğlu S; Berker S; Yeğin O
Acta Haematol; 1994; 92(1):36-8. PubMed ID: 7985480
[TBL] [Abstract][Full Text] [Related]
43. A new nonrandom unbalanced t(17;20) in myeloid malignancies.
Patsouris C; Michael PM; Campbell LJ
Cancer Genet Cytogenet; 2002 Oct; 138(1):32-7. PubMed ID: 12419582
[TBL] [Abstract][Full Text] [Related]
44. Immunophenotypic Features of Myeloid Neoplasms Associated with Chromosome 7 Abnormalities.
Chen X; Wood BL; Cherian S
Cytometry B Clin Cytom; 2019 Jul; 96(4):300-309. PubMed ID: 30806023
[TBL] [Abstract][Full Text] [Related]
45. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
[TBL] [Abstract][Full Text] [Related]
46. Simple monosomy 7 and myelodysplastic syndrome in thirteen patients without previous cytostatic treatment.
Michiels JJ; Mallios-Zorbala H; Prins ME; Hählen K; Hagemeijer A
Br J Haematol; 1986 Nov; 64(3):425-33. PubMed ID: 3466639
[TBL] [Abstract][Full Text] [Related]
47. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).
Kanagal-Shamanna R; Yin CC; Miranda RN; Bueso-Ramos CE; Wang XI; Muddasani R; Medeiros LJ; Lu G
Cancer Genet; 2013; 206(1-2):42-6. PubMed ID: 23357231
[TBL] [Abstract][Full Text] [Related]
48. Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remission.
Engel H; Goodacre A; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Andreeff M
Br J Haematol; 1997 Oct; 99(1):64-75. PubMed ID: 9359505
[TBL] [Abstract][Full Text] [Related]
49. Unbalanced translocations of 20q in AML and MDS often involve interstitial rather than terminal deletions of 20q.
MacKinnon RN; Duivenvoorden HM; Campbell LJ
Cancer Genet; 2011 Mar; 204(3):153-61. PubMed ID: 21504715
[TBL] [Abstract][Full Text] [Related]
50. Myelodysplastic syndrome with Ph negative monosomy 7 chromosome following transient bone marrow dysplasia during imatinib treatment for chronic myeloid leukemia.
Karimata K; Masuko M; Ushiki T; Kozakai T; Shibasaki Y; Yano T; Abe T; Moriyama M; Toba K; Furukawa T; Aizawa Y
Intern Med; 2011; 50(5):481-5. PubMed ID: 21372464
[TBL] [Abstract][Full Text] [Related]
51. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases.
Braun T; de Botton S; Taksin AL; Park S; Beyne-Rauzy O; Coiteux V; Sapena R; Lazareth A; Leroux G; Guenda K; Cassinat B; Fontenay M; Vey N; Guerci A; Dreyfus F; Bordessoule D; Stamatoullas A; Castaigne S; Terré C; Eclache V; Fenaux P; Adès L
Leuk Res; 2011 Jul; 35(7):863-7. PubMed ID: 21396711
[TBL] [Abstract][Full Text] [Related]
52. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
53. Single-cell dissection of monosomy 7 syndromes.
Gutierrez-Perez I; Bryceson YT
Blood; 2017 Dec; 130(25):2693-2695. PubMed ID: 29269530
[No Abstract] [Full Text] [Related]
54. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
[TBL] [Abstract][Full Text] [Related]
55. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
[TBL] [Abstract][Full Text] [Related]
56. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
Pitchford CW; Hettinga AC; Reichard KK
Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235
[TBL] [Abstract][Full Text] [Related]
57. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
[TBL] [Abstract][Full Text] [Related]
58. Cytogenetic analysis in patients with myelodysplastic syndrome.
Hu N; Bian M
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):135-9. PubMed ID: 2098765
[TBL] [Abstract][Full Text] [Related]
59. 3p21 is a recurrent treatment-related breakpoint in myelodysplastic syndrome and acute myeloid leukemia.
Shi G; Weh HJ; Martensen S; Seeger D; Hossfeld DK
Cytogenet Cell Genet; 1996; 74(4):295-9. PubMed ID: 8976389
[TBL] [Abstract][Full Text] [Related]
60. Detection of myelodysplastic syndrome/ acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF.
Imashuku S; Hibi S; Bessho F; Tsuchida M; Nakahata T; Miyazaki S; Tsukimoto I; Hamajima N;
Haematologica; 2003 Nov; 88(11):ECR31. PubMed ID: 14607763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
